Certara Products Archives

White Paper

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

Since 2019, the Institute for Clinical and Economic Review (ICER) has published an annual Unsupported…

CertaraJuly 25, 2023

Publication

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…

CertaraJune 28, 2023

On-Demand Webinar

What’s New for SEND 2023

This webinar will focus on several changes to the CDISC SEND standard that became active…

CertaraJune 12, 2023

Case Study

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Blog

SEND Dataset Quality Control: Best Practices & Recommendations

In this blog, Senior Product Management Director Peggy Zorn explores best practices & recommendations for…

CertaraApril 25, 2023

Case Study

Repurposing Data & Advanced Analytics to Validate Surrogate Endpoints

Repurposed data and advanced analytics can be used to validate a surrogate endpoint. A surrogate…

CertaraApril 13, 2023

Article

LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data

Published: April 12, 2023 This is the German article written by Dr. Fabian Rauscher, Scientific…

CertaraApril 12, 2023

On-Demand Webinar

Data Visualization with SEND Data to See What Happened at the Preclinical Phase

SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…

CertaraFebruary 9, 2023

White Paper

The eCTD Submission Process: Tips and Tricks for Drug Development Success

Our experts compiled the tips and best practices you need to know for a successful…

CertaraNovember 22, 2022

Case Study

Providing Around-the-Clock Regulatory Support While Enhancing Team Chemistry

Advaxis Inc. is devoted to the discovery, development, and commercialization of immunotherapies based on a…

CertaraJune 3, 2022

Certara Products

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome

What’s New for SEND 2023

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

SEND Dataset Quality Control: Best Practices & Recommendations

Repurposing Data & Advanced Analytics to Validate Surrogate Endpoints

LABO: Data utilisation and data infrastructure in drug development: Data, Data, Data

Data Visualization with SEND Data to See What Happened at the Preclinical Phase

The eCTD Submission Process: Tips and Tricks for Drug Development Success

Providing Around-the-Clock Regulatory Support While Enhancing Team Chemistry

Newsletter sign up

Quick links

Solutions

Contact